The integration of artificial intelligence (AI) into Joint Clinical Assessment (JCA) processes is transforming how health technology developers (HTDs) prepare for evidence submissions. The challenge lies in anticipating the specific evidence required by the HTA Coordination Group, which can often feel like preparing for an unknown query.
HTDs are increasingly utilizing AI to enhance the efficiency and quality of PICO (Problem, Intervention, Comparison, Outcome) planning. While AI excels at synthesizing large datasets and identifying relevant precedents, it cannot predict the precise criteria that will be deemed essential in future assessments. This limitation highlights the necessity for expert interpretation to contextualize AI-generated insights within the evolving reimbursement landscape.
AI tools can expedite the identification and summarization of critical information, including prior HTA assessments and clinical guidelines. However, the interpretation of this data requires the nuanced understanding of experienced professionals who can align findings with current reimbursement expectations and validate PICO assumptions. Engaging with clinicians and payers early in the planning process also provides valuable insights into real-world practices and unmet needs, ensuring that assessments focus on clinically meaningful outcomes.
Ultimately, while AI streamlines the evidence-gathering process, the human expertise in interpreting these insights remains indispensable. Companies like Clarivate are leveraging this synergy between AI and expert knowledge to enhance PICO readiness, thereby reducing risks associated with evidence gaps and ensuring that submissions meet evolving HTA requirements. This collaborative approach is crucial for navigating the complexities of JCA and improving the likelihood of successful outcomes.